Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL-2) in …

SR Johnston, DO Constenla, J Moore… - British journal of …, 1998 - nature.com
The purpose of this study was to evaluate in a randomized phase II trial the efficacy and
toxicity of combination biochemotherapy compared with chemotherapy alone in patients with …
被引用次数：79 相关文章
[PDF] researchgate.net

[PDF][PDF] Randomized phase 11 trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-oc) and interleukin …

J SRD, J Constenlal, RP Atkinson… - British Journal of …, 1998 - researchgate.net
Thepurpose of this study wasto evaluate in a randomized phase II trial the efficacy and
toxicity of combination biochemotherapy compared with chemotherapy alone in patients with …

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) …

SR Johnston, DO Constenla, J Moore… - British journal of …, 1998 - pubmed.ncbi.nlm.nih.gov
The purpose of this study was to evaluate in a randomized phase II trial the efficacy and
toxicity of combination biochemotherapy compared with chemotherapy alone in patients with …

[引用][C] Randomized phase II trial of BCDT (carmustine, cisplatin, dacarbazine and tamoxifen) with or without interferon alpha and interleukin-2 in patients with …

SR JOHNSTON - Br. J. Cancer, 1998 - cir.nii.ac.jp
Randomized phase II trial of BCDT (carmustine, cisplatin, dacarbazine and tamoxifen) with or
without interferon alpha and interleukin-2 in patients with metastatic melanoma | CiNii …

[引用][C] Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL …

SRD JOHNSTON, DO CONSTENLA… - British journal of …, 1998 - pascal-francis.inist.fr
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and
tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL-2) in patients with …

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) …

SR Johnston, DO Constenla, J Moore… - British Journal of …, 1998 - europepmc.org
The purpose of this study was to evaluate in a randomized phase II trial the efficacy and
toxicity of combination biochemotherapy compared with chemotherapy alone in patients with …

Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) …

SR Johnston, DO Constenla, J Moore… - British Journal of …, 1998 - ncbi.nlm.nih.gov
The purpose of this study was to evaluate in a randomized phase II trial the efficacy and
toxicity of combination biochemotherapy compared with chemotherapy alone in patients with …
[PDF] psu.edu

[PDF][PDF] Randomized phase 11 trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-oc) and interleukin …

J SRD, J Constenlal, RP Atkinson, PG Dadian - British Journal of Cancer, 1998 - Citeseer
Thepurpose of this study wasto evaluate in a randomized phase II trial the efficacy and
toxicity of combination biochemotherapy compared with chemotherapy alone in patients with …

[引用][C] Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-α) and interleukin (IL …

SRD JOHNSTON, DO CONSTENLA… - British journal of …, 1998 - Nature Publishing Group